CD73 has been shown to be increased in tumor tissues in comparison to normal control samples, and higher CD73 is generally correlated to a worse prognosis in multiple types of human cancers, including CRCs [8,9,10,11,12]. This evidence concerns the gene NT5E and neoplasm.